Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-19.
Fernanda Pereira MonteiroVictor de Souza TavaresRayane da Silva Oliveira SouzaLarissa Paola Rodrigues VenâncioMary Hellen Fabres-KleinRodrigo Feliciano do CarmoRaphael Contelli KleinJonilson Berlink LimaThéo Araujo-SantosPublished in: Memorias do Instituto Oswaldo Cruz (2023)
Our data suggest that IgG against NP and RBD participates in the worsening of COVID-19. Although the humoral response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is partially understood, and more efforts are needed to clarify gaps in the knowledge of this process.